Jorge Mas - Mar 18, 2025 Form 4 Insider Report for MASTEC INC (MTZ)

Role
Director
Signature
\s\ Alberto de Cardenas For: Jorge Mas
Stock symbol
MTZ
Transactions as of
Mar 18, 2025
Transactions value $
$0
Form type
4
Date filed
3/20/2025, 05:40 PM
Previous filing
Sep 10, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MTZ Common Stock Award $0 +37K +0.82% $0.00 4.56M Mar 18, 2025 Direct
holding MTZ Common Stock 849K Mar 18, 2025 Indirect F1
holding MTZ Common Stock 276K Mar 18, 2025 Indirect F2
holding MTZ Common Stock 100K Mar 18, 2025 Indirect F3
holding MTZ Common Stock 5.67M Mar 18, 2025 Indirect F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held by the Jorge Mas Irrevocable Family Trust dated August 7, 2018, one of the trustees of which is the reporting person's spouse. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purpose of Section 16 or for any other purpose.
F2 Shares owned by Mas Equity Partners III, LLC, a Delaware limited liability company ("MEP III"), in which Mas Equity Partners, LLC ("MEP") is a member. The sole member of MEP is the reporting person. The reporting person disclaims beneficial ownership of the securities held by MEP III except to the extent of his pecuniary interest therein.
F3 Shares owned of record by the Mas Family Foundation, Inc., a Florida not-for-profit corporation (the "Family Foundation"), of which the reporting person is the president. The reporting person disclaims beneficial ownership of all shares owned by the Family Foundation.
F4 Shares owned of record by Jorge Mas Holdings I, LLC, a Florida limited liability company, which is controlled by Jorge Mas Holdings, LLC, a Florida limited liability company, of which the reporting person is the sole member.